Role of Smooth Muscle cGMP/cGKI Signaling in Murine Vascular Restenosis
Open Access
- 1 July 2008
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 28 (7), 1244-1250
- https://doi.org/10.1161/ATVBAHA.108.166405
Abstract
Background— Nitric oxide (NO) is of crucial importance for smooth muscle cell (SMC) function and exerts numerous, and sometimes opposing, effects on vascular restenosis. Although cGMP-dependent protein kinase type I (cGKI) is a principal effector of NO, the molecular pathway of vascular NO signaling in restenosis is unclear. The purpose of this study was to examine the functional role of the smooth muscle cGMP/cGKI signaling cascade in restenosis of vessels. Methods and Results— Tissue-specific mouse mutants were generated in which the cGKI protein was ablated in SMCs. We investigated whether the absence of cGKI in SMCs would affect vascular remodeling after carotid ligation or removal of the endothelium. No differences were detected between the tissue-specific cGKI mutants and control mice at different time points after vascular injury on a normolipidemic or apoE-deficient background. In line with these results, chronic drug treatment of injured control mice with the phosphodiesterase-5 inhibitor sildenafil elevated cGMP levels but had no influence on the ligation-induced remodeling. Conclusions— The genetic and pharmacological manipulation of the cGMP/cGKI signaling indicates that this pathway is not involved in the protective effects of NO, suggesting that NO affects vascular remodeling during restenosis via alternative mechanisms.Keywords
This publication has 46 references indexed in Scilit:
- Cysteine-674 of the Sarco/Endoplasmic Reticulum Calcium ATPase Is Required for the Inhibition of Cell Migration by Nitric OxideArteriosclerosis, Thrombosis, and Vascular Biology, 2007
- A heretical view on the role of NO and cGMP in vascular proliferative diseasesTrends in Molecular Medicine, 2005
- Distribution of IRAG and cGKI‐isoforms in murine tissuesFEBS Letters, 2004
- Vasculoprotective Roles of Neuronal Nitric Oxide SynthaseThe FASEB Journal, 2002
- cGMP-Dependent Protein Kinase Expression Restores Contractile Function in Cultured Vascular Smooth Muscle CellsJournal of Vascular Research, 2002
- YC-1-Mediated Vascular Protection through Inhibition of Smooth Muscle Cell Proliferation and Platelet FunctionBiochemical and Biophysical Research Communications, 2002
- cGMP-Dependent Protein Kinase I Mediates the Negative Inotropic Effect of cGMP in the Murine MyocardiumCirculation Research, 2002
- Pressure-Induced Upregulation of Preproendothelin-1 and Endothelin B Receptor Expression in Rabbit Jugular Vein In SituArteriosclerosis, Thrombosis, and Vascular Biology, 2000
- Adenovirus-mediated Gene Transfer of cGMP-dependent Protein Kinase Increases the Sensitivity of Cultured Vascular Smooth Muscle Cells to the Antiproliferative and Pro-apoptotic Effects of Nitric Oxide/cGMPPublished by Elsevier BV ,1998
- Expression of cGMP‐dependent protein kinase I and its substrate VASP in neointimal cells of the injured rat carotid arteryEuropean Journal of Clinical Investigation, 1998